Immunogenicity 15223
Sample ID
3926
Response
Negative
Tumor Type
Melanoma
Gene Symbol
TRIL
Transcript ID
uc003szt.3
HLA INFO
B*13:02
TCR INFO
No TCR info found!
Full length protein sequence (811 aa)
MEAAR
1
ALRLL
6
LVVCG
11
CLALP
16
PLAEP
21
VCPER
26
CDCQH
31
PQHLL
36
CTNRG
41
LRVVP
46
KTSSL
51
PSPHD
56
VLTYS
61
LGGNF
66
ITNIT
71
AFDFH
76
RLGQL
81
RRLDL
86
QYNQI
91
RSLHP
96
KTFEK
101
LSRLE
106
ELYLG
111
NNLLQ
116
ALAPG
121
TLAPL
126
RKLRI
131
LYANG
136
NEISR
141
LSRGS
146
FEGLE
151
SLVKL
156
RLDGN
161
ALGAL
166
PDAVF
171
APLGN
176
LLYLH
181
LESNR
186
IRFLG
191
KNAFA
196
QLGKL
201
RFLNL
206
SANEL
211
QPSLR
216
HAATF
221
APLRS
226
LSSLI
231
LSANN
236
LQHLG
241
PRIFQ
246
HLPRL
251
GLLSL
256
RGNQL
261
THLAP
266
EAFWG
271
LEALR
276
ELRLE
281
GNRLS
286
QLPTA
291
LLEPL
296
HSLEA
301
LDLSG
306
NELSA
311
LHPAT
316
FGHLG
321
RLREL
326
SLRNN
331
ALSAL
336
SGDIF
341
AASPA
346
LYRLD
351
LDGNG
356
WTCDC
361
RLRGL
366
KRWMG
371
DWHSQ
376
GRLLT
381
VFVQC
386
RHPPA
391
LRGKY
396
LDYLD
401
DQQLQ
406
NGSCA
411
DPSPS
416
ASLTA
421
DRRRQ
426
PLPTA
431
AGEEM
436
TPPAG
441
LAEEL
446
PPQPQ
451
LQQQG
456
RFLAG
461
VAWDG
466
AAREL
471
VGNRS
476
ALRLS
481
RRGPG
486
LQQPS
491
PSVAA
496
AAGPA
501
PQSLD
506
LHKKP
511
QRGRP
516
TRADP
521
ALAEP
526
TPTAS
531
PGSAP
536
SPAGD
541
PWQRA
546
TKHRL
551
GTEHQ
556
ERAAQ
561
SDGGA
566
GLPPL
571
VSDPC
576
DFNKF
581
ILCNL
586
TVEAV
591
GADSA
596
SVRWA
601
VREHR
606
SPRPL
611
GGARF
616
RLLFD
621
RFGQQ
626
PKFHR
631
FVYLP
636
ESSDS
641
ATLRE
646
LRGDT
651
PYLVC
656
VEGVL
661
GGRVC
666
PVAPR
671
DHCAG
676
LVTLP
681
EAGSR
686
GGVDY
691
QLLTL
696
ALLTV
701
NALLV
706
LLALA
711
AWASR
716
WLRRK
721
LRARR
726
KGGAP
731
VHVRH
736
MYSTR
741
RPLRS
746
MGTGV
751
SADFS
756
GFQSH
761
RPRTT
766
VCALS
771
EADLI
776
EFPCD
781
RFMDS
786
AGGGA
791
GGSLR
796
REDRL
801
LQRFA
806
D
811
Mutation Information
DNA mutation:
None
Peptide Range:
492 ~ 516
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"QQPSPSVAAAAGPAPQSLDLHKKPQ
||||||||||||.||||||||||||
Mutant:
QQPSPSVAAAAGLAPQSLDLHKKPQ"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) TRIL
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay